Knowledge Resource Center for Ecological Environment in Arid Area
DOI | 10.3389/fcell.2021.691161 |
Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction | |
Gao, Yang; Zhang, Enchong; Fei, Xiang; Kong, Lingming; Liu, Peng; Tan, Xiaodong | |
通讯作者 | Tan, XD (corresponding author), China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang, Peoples R China. |
来源期刊 | FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
![]() |
ISSN | 2296-634X |
出版年 | 2021 |
卷号 | 9 |
英文摘要 | Pancreatic cancer (PanC) is an intractable malignancy with a high mortality. Metabolic processes contribute to cancer progression and therapeutic responses, and histopathological subtypes are insufficient for determining prognosis and treatment strategies. In this study, PanC subtypes based on metabolism-related genes were identified and further utilized to construct a prognostic model. Using a cohort of 171 patients from The Cancer Genome Atlas (TCGA) database, transcriptome data, simple nucleotide variants (SNV), and clinical information were analyzed. We divided patients with PanC into metabolic gene-enriched and metabolic gene-desert subtypes. The metabolic gene-enriched subgroup is a high-risk subtype with worse outcomes and a higher frequency of SNVs, especially in KRAS. After further characterizing the subtypes, we constructed a risk score algorithm involving multiple genes (i.e., NEU2, GMPS, PRIM2, PNPT1, LDHA, INPP4B, DPYD, PYGL, CA12, DHRS9, SULT1E1, ENPP2, PDE1C, TPH1, CHST12, POLR3GL, DNMT3A, and PGS1). We verified the reproducibility and reliability of the risk score using three validation cohorts (i.e., independent datasets from TCGA, Gene Expression Omnibus, and Ensemble databases). Finally, drug prediction was completed using a ridge regression model, yielding nine candidate drugs for high-risk patients. These findings support the classification of PanC into two metabolic subtypes and further suggest that the metabolic gene-enriched subgroup is associated with worse outcomes. The newly established risk model for prognosis and therapeutic responses may improve outcomes in patients with PanC. |
英文关键词 | pancreatic cancer transcriptome metabolic genes subtype risk model |
类型 | Article |
语种 | 英语 |
开放获取类型 | Green Published, gold |
收录类别 | SCI-E |
WOS记录号 | WOS:000684954500009 |
WOS关键词 | MOLECULAR SUBTYPES ; PRECISION MEDICINE ; GENE ; TUMOR ; METHYLATION ; BALANCE |
WOS类目 | Cell Biology ; Developmental Biology |
WOS研究方向 | Cell Biology ; Developmental Biology |
资源类型 | 期刊论文 |
条目标识符 | http://119.78.100.177/qdio/handle/2XILL650/363277 |
作者单位 | [Gao, Yang; Fei, Xiang; Kong, Lingming; Liu, Peng; Tan, Xiaodong] China Med Univ, Shengjing Hosp, Dept Gen Surg, Shenyang, Peoples R China; [Zhang, Enchong] China Med Univ, Shengjing Hosp, Dept Urol, Shenyang, Peoples R China |
推荐引用方式 GB/T 7714 | Gao, Yang,Zhang, Enchong,Fei, Xiang,et al. Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction[J],2021,9. |
APA | Gao, Yang,Zhang, Enchong,Fei, Xiang,Kong, Lingming,Liu, Peng,&Tan, Xiaodong.(2021).Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction.FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY,9. |
MLA | Gao, Yang,et al."Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction".FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY 9(2021). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。